| 注册
首页|期刊导航|肿瘤药学|慢性肾功能衰竭合并肿瘤患者应用透析联合缬沙坦的效果及其对生存时间的影响

慢性肾功能衰竭合并肿瘤患者应用透析联合缬沙坦的效果及其对生存时间的影响

高希 王爽 屠恩玲 贾艳红 王英

肿瘤药学2018,Vol.8Issue(1):40-43,4.
肿瘤药学2018,Vol.8Issue(1):40-43,4.DOI:10.3969/j.issn.2095-1264.2018.01.09

慢性肾功能衰竭合并肿瘤患者应用透析联合缬沙坦的效果及其对生存时间的影响

Effect of Hemodialysis Combined with Valsartan for the Treatment of Patients with Chronic Renal Failure Combined with Tumor

高希 1王爽 1屠恩玲 1贾艳红 1王英1

作者信息

  • 1. 首都医科大学附属北京世纪坛医院 透析室,北京,100038
  • 折叠

摘要

Abstract

Objective To investigate the clinical effect of hemodialysis combined with valsartan for the treatment of patients with chronic renal failure combined with tumor. Methods 92 patients with chronic renal failure combined with tumor were selected in our hospital from July 2013 to August 2017. According to the random number method, they were divided into control group and research group. The patients in control group were treated with hemodialysis, and the patients in research group were treated with hemodialysis combined with valsartan. The effective rate and incidence of complications were compared between the two groups after treatment. The renal function contrast after treatment and the survival rate within five years after operation were compared. Results After treatment, the effective rate of patients in the research group was significantly higher than that in the control group (P<0.05); the postoperative anemia, hypertension, heart failure and aluminum poisoning complication rate of patients in research group were significantly lower than these in the control group (P<0.05); the renal function indexes of patients in the two groups had no significant difference before treatment (P>0.05) after treatment, serum creatinine and urea nitrogen levels of patients in research group were significantly lower than these in the control group (P<0.05), creatinine level was increased significantly in the research group compared with that in the control group (P<0.05); three years, five years survival rate of patients in the research group after treatment were significantly higher than these in the control group (P<0.05). Conclusion Hemodialysis combined with valsartan can significantly improve the treatment efficiency, renal function, and the survival time of patients with chronic renal failure and tumor. It is worthy of further promotion and application in clinic.

关键词

慢性肾功能衰竭/肿瘤/透析/缬沙坦/肾功能

Key words

Chronic renal failure/Tumor/Hemodialysis/Valsartan/Renal function

分类

医药卫生

引用本文复制引用

高希,王爽,屠恩玲,贾艳红,王英..慢性肾功能衰竭合并肿瘤患者应用透析联合缬沙坦的效果及其对生存时间的影响[J].肿瘤药学,2018,8(1):40-43,4.

基金项目

国家科技支撑计划课题(2013BAI09B04 ()

2015BAI12B05) ()

首都医科大学第二课堂项目(D2KT2015). (D2KT2015)

肿瘤药学

OACSTPCD

2095-1264

访问量0
|
下载量0
段落导航相关论文